JANX — Janux Therapeutics, Inc. | XLV Holdings | StockAdder

(JANX)

Janux Therapeutics, Inc.

Live chart and latest JANX stock news.

Sector ETF → XLV Health Care Select

Chart powered byTradingView— professional charts for every trader.Try it free →

JANX News

Insider sales and option exercises reported for JANX (JANX) in Form 144 filing

Apr 13, 2026 Yahoo Finance

Where is Janux Therapeutics (JANX) Headed According to Analysts?

Feb 19, 2026 Barron's

Janux Therapeutics Stock Craters After ‘Positive’ Cancer Data. Why It’s Down 50%.

Dec 2, 2025 Investor's Business Daily

Janux Therapeutics Craters 53% On Prostate Cancer Update; Is It An 'Overreaction'?

Dec 2, 2025 simplywall.st

Reassessing Janux Therapeutics (JANX) Valuation After Mixed Market Reaction to New JANX007 Phase 1 Data

Dec 8, 2025 Yahoo Finance

Why Wall Street Sees Big Potential in Janux Therapeutics, Inc. (JANX)

Dec 27, 2025 Stock Titan

Bristol Myers-backed cancer program lands Janux a $35 million milestone

Apr 1, 2026 Yahoo Finance

Janux Therapeutics, Inc. (JANX) Faces Platform Risk Amid Lack of Durability Data on JANX007

Feb 2, 2026 Stock Titan

71,016 shares tied to option exercise at JANX (NASDAQ: JANX) disclosed

Apr 2, 2026 Yahoo Finance

Janux Therapeutics (JANX): Valuation Check After Positive JANX007 Phase 1 Data and Sharp Share Price Drop

Dec 4, 2025 Stock Titan

New immune therapy targeting EGFR moves into broader cancer testing

Dec 23, 2025 Yahoo Finance

Janux Therapeutics (JANX) Gets Initiated With a Buy Rating at Truist Financial

Oct 20, 2025 Stock Titan

Janux (Nasdaq: JANX) Schedules Virtual Event on JANX007 Phase 1a/1b mCRPC Data

Nov 24, 2025 Yahoo Finance

Janux Therapeutics, Inc. (JANX) Reports Q3 Loss, Tops Revenue Estimates

Nov 6, 2025 Yahoo Finance

Wall Street Analysts See a 319.23% Upside in Janux Therapeutics (JANX): Can the Stock Really Move This High?